Hypertension (Drugs) Flashcards
Captopril
ACE Inhibitor
- Treats Hypertension
MOA:
- Inhibits ACE, preventing Ang II generation
Valsartan
Angiotensin Receptor Blocker (ARBs)
- Treats Hypertension
MOA:
- Inhibits AT1 Receptor on SMC
Bendroflumethiazide
Thiazide (Mild Diuretic)
- Treats Hypertension
MOA:
- Binds and inhibits Distal Tubular Na+/Cl- cotransporter
–> Decreases Blood Volume –>Decrease BP
Dihydropyridine
Class of L-Type Voltage Gated Channel Antagonists
- Treats Hypertension
MOA:
- Reduces Ca2+ into SMC
–> Arterial Dilation –> Reduces BP
Nifedipine
L-Type Voltage Gated Channel Antagonists
- Treats Hypertension
- Treats Pregnancy Hypertension
MOA:
- Reduces Ca2+ into SMC
–> Arterial Dilation –> Reduces BP
Amlodipine
L-Type Voltage Gated Channel Antagonists
- Treats Hypertension
MOA:
- Reduces Ca2+ into SMC
–> Arterial Dilation –> Reduces BP
Nicardipine
L-Type Voltage Gated Channel Antagonists
- Treats Hypertension
MOA:
- Reduces Ca2+ into SMC
–> Arterial Dilation –> Reduces BP
Felodipine
L-Type Voltage Gated Channel Antagonists
- Treats Hypertension
MOA:
- Reduces Ca2+ into SMC
–> Arterial Dilation –> Reduces BP
Prazosin
Alpha1 Adrenoceptor Antagonist
- Treats Hypertension
MOA:
- Blocks NE action on vascular SMC
–> Vasodilation + Reduce Arterial Pressure
–> Reduce BP
Propranolol
Beta1 Adrenoceptor Antagonist
(Non-selective)
- Treats Hypertension
MOA:
- Reduce cardiac output
- Reduce renin release from kidneys
- Reduce sympathetic activity
Alprenolol
Beta1 Adrenoceptor Antagonist
(Non-selective)
- Treats Hypertension
MOA:
- Reduce cardiac output
- Reduce renin release from kidneys
- Reduce sympathetic activity
Metoprolol
Beta1 Adrenoceptor Antagonist
(Beta1-Selective)
- Treats Hypertension
MOA:
- Reduce cardiac output
- Reduce renin release from kidneys
- Reduce sympathetic activity
Nebivolol
Beta1 Adrenoceptor Antagonist
(Beta1 Selective)
- Treats Hypertension
MOA:
- Enhances NO production
–> Vasodilator
Nitroprusside
Powerful Vasodilator
- Used to treat hypertensive emergencies
MOA:
- NO donator
–> Simulates cGMP signaling –> Acts on arterial and venous smooth muscle
- Generates Cyanide
- Short term use (72 hours max)
Methyldopa
Pregnancy Hypertension Treatments
MOA:
Converted into methylnoradrenaline
–> Less active than NA
–> Decreases sympathetic activity on smooth muscle